Haleon plc (NYSE:HLN) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Haleon plc (NYSE:HLN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine ratings firms that are covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $11.25.

Several analysts recently commented on HLN shares. HSBC reiterated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target on the stock in a research note on Friday, May 9th. Barclays reissued an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Haleon in a report on Monday, March 3rd.

Institutional Trading of Haleon

A number of hedge funds have recently made changes to their positions in the company. Sierra Ocean LLC acquired a new stake in shares of Haleon during the fourth quarter worth approximately $26,000. Bartlett & CO. Wealth Management LLC raised its stake in shares of Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after purchasing an additional 1,491 shares in the last quarter. Opal Wealth Advisors LLC bought a new stake in shares of Haleon during the first quarter valued at about $29,000. Deutsche Bank AG raised its stake in shares of Haleon by 267.8% during the first quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock valued at $32,000 after purchasing an additional 2,276 shares in the last quarter. Finally, Geneos Wealth Management Inc. bought a new stake in Haleon in the fourth quarter worth about $35,000. Hedge funds and other institutional investors own 6.67% of the company's stock.

Haleon Trading Up 2.5%

NYSE HLN opened at $10.66 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon has a 52 week low of $8.25 and a 52 week high of $10.85. The stock has a market capitalization of $48.06 billion, a PE ratio of 31.35, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24. The firm has a 50 day moving average of $10.21 and a two-hundred day moving average of $9.86.

Haleon (NYSE:HLN - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The business had revenue of $3.54 billion during the quarter, compared to analysts' expectations of $3.38 billion. As a group, research analysts expect that Haleon will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The company also recently disclosed a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be paid a dividend of $0.1166 per share. The ex-dividend date is Friday, April 25th. This represents a dividend yield of 1.6%. This is a positive change from Haleon's previous -- dividend of $0.05. Haleon's dividend payout ratio (DPR) is currently 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.